Christina Bluemel1, Andreas Cramer2, Christoph Grossmann2, Georg W Kajdi3, Uwe Malzahn4, Nora Lamp5, Heinz-Jakob Langen6, Jan Schmid3, Andreas K Buck3, Hanns-Jörg Grimminger2, Ken Herrmann3. 1. Department of Nuclear Medicine, University Hospital of Würzburg, Oberdürrbacher Str. 6, 97080, Würzburg, Germany. Bluemel_c@ukw.de. 2. Department of Obstetrics and Gynecology, Missionsärztliches Klinikum Würzburg, Würzburg, Germany. 3. Department of Nuclear Medicine, University Hospital of Würzburg, Oberdürrbacher Str. 6, 97080, Würzburg, Germany. 4. Institute of Clinical Epidemiology and Biometry, University of Würzburg, Würzburg, Germany. 5. Institute of Pathology, University of Würzburg, Würzburg, Germany. 6. Department of Radiology, Missionsärztliches Klinikum Würzburg, Würzburg, Germany.
Abstract
PURPOSE: To prospectively evaluate the feasibility of 3-D radioguided occult lesion localization (iROLL) and to compare iROLL with wire-guided localization (WGL) in patients with early-stage breast cancer undergoing breast-conserving surgery and sentinel lymph node biopsy (SLNB). METHODS: WGL (standard procedure) and iROLL in combination with SLNB were performed in 31 women (mean age 65.1 ± 11.2 years) with early-stage breast cancer and clinically negative axillae. Patient comfort in respect of both methods was assessed using a ten point scale. SLNB and iROLL were guided by freehand SPECT (fhSPECT). The results of the novel 3-D image-based method were compared with those of WGL, ultrasound-based lesion localization, and histopathology. RESULTS: iROLL successfully detected the malignant primary and at least one sentinel lymph node in 97% of patients. In a single patient (3%), only iROLL, and not WGL, enabled lesion localization. The variability between fhSPECT and ultrasound-based depth localization of breast lesions was low (1.2 ± 1.4 mm). Clear margins were achieved in 81% of the patients; however, precise prediction of clear histopathological surgical margins was not feasible using iROLL. Patients rated iROLL as less painful than WGL with a pain score 0.8 ± 1.2 points (p < 0.01) lower than the score for iROLL. CONCLUSION: iROLL is a well-tolerated and feasible technique for localizing early-stage breast cancer in the course of breast-conserving surgery, and is a suitable replacement for WGL. As a single image-based procedure for localization of breast lesions and sentinel nodes, iROLL may improve the entire surgical procedure. However, no advantages of the image-guided procedure were found with regard to prediction of complete tumour resection.
PURPOSE: To prospectively evaluate the feasibility of 3-D radioguided occult lesion localization (iROLL) and to compare iROLL with wire-guided localization (WGL) in patients with early-stage breast cancer undergoing breast-conserving surgery and sentinel lymph node biopsy (SLNB). METHODS: WGL (standard procedure) and iROLL in combination with SLNB were performed in 31 women (mean age 65.1 ± 11.2 years) with early-stage breast cancer and clinically negative axillae. Patient comfort in respect of both methods was assessed using a ten point scale. SLNB and iROLL were guided by freehand SPECT (fhSPECT). The results of the novel 3-D image-based method were compared with those of WGL, ultrasound-based lesion localization, and histopathology. RESULTS: iROLL successfully detected the malignant primary and at least one sentinel lymph node in 97% of patients. In a single patient (3%), only iROLL, and not WGL, enabled lesion localization. The variability between fhSPECT and ultrasound-based depth localization of breast lesions was low (1.2 ± 1.4 mm). Clear margins were achieved in 81% of the patients; however, precise prediction of clear histopathological surgical margins was not feasible using iROLL. Patients rated iROLL as less painful than WGL with a pain score 0.8 ± 1.2 points (p < 0.01) lower than the score for iROLL. CONCLUSION: iROLL is a well-tolerated and feasible technique for localizing early-stage breast cancer in the course of breast-conserving surgery, and is a suitable replacement for WGL. As a single image-based procedure for localization of breast lesions and sentinel nodes, iROLL may improve the entire surgical procedure. However, no advantages of the image-guided procedure were found with regard to prediction of complete tumour resection.
Authors: P Paredes; S Vidal-Sicart; G Zanón; N Roé; S Rubí; S Lafuente; J Pavía; F Pons Journal: Eur J Nucl Med Mol Imaging Date: 2007-11-28 Impact factor: 9.236
Authors: Christina Bluemel; Andreas Schnelzer; Asli Okur; Alexandra Ehlerding; Stefan Paepke; Klemens Scheidhauer; Marion Kiechle Journal: Eur J Nucl Med Mol Imaging Date: 2013-06-11 Impact factor: 9.236
Authors: E L Postma; H M Verkooijen; S van Esser; M G Hobbelink; G P van der Schelling; R Koelemij; A J Witkamp; C Contant; P J van Diest; S M Willems; I H M Borel Rinkes; M A A J van den Bosch; W P Mali; R van Hillegersberg Journal: Breast Cancer Res Treat Date: 2012-09-30 Impact factor: 4.872
Authors: F Giammarile; N Alazraki; J N Aarsvold; R A Audisio; E Glass; S F Grant; J Kunikowska; M Leidenius; V M Moncayo; R F Uren; W J Oyen; R A Valdés Olmos; S Vidal Sicart Journal: Eur J Nucl Med Mol Imaging Date: 2014-03-26 Impact factor: 9.236
Authors: Antonio Mariscal Martínez; Montse Solà; Anna Pérez de Tudela; Juan Francisco Julián; Manuel Fraile; Sara Vizcaya; Jaume Fernández Journal: AJR Am J Roentgenol Date: 2009-10 Impact factor: 3.959
Authors: Christina Bluemel; Gonca Safak; Andreas Cramer; Achim Wöckel; Anja Gesierich; Elena Hartmann; Jan-Stefan Schmid; Franz Kaiser; Andreas K Buck; Ken Herrmann Journal: Eur J Nucl Med Mol Imaging Date: 2016-06-17 Impact factor: 9.236